Cite
HARVARD Citation
Rossignol, J. et al. (n.d.). Radioimmunotherapy (90Y‐Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab. American journal of transplantation. 15 (7), pp. 1976-1981. [Online].